相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo
Nadine Jetten et al.
ANGIOGENESIS (2014)
Pazopanib exposure decreases as a result of an ifosfamide-dependent drug-drug interaction: results of a phase I study
P. Hamberg et al.
BRITISH JOURNAL OF CANCER (2014)
Role of Inflammation-Associated Microenvironment in Tumorigenesis and Metastasis
Feng Gao et al.
CURRENT CANCER DRUG TARGETS (2014)
Epigenetic control of hypoxia inducible factor-1α-dependent expression of placental growth factor in hypoxic conditions
Laura Tudisco et al.
EPIGENETICS (2014)
Growth Factors Engineered for Super-Affinity to the Extracellular Matrix Enhance Tissue Healing
Mikael M. Martino et al.
SCIENCE (2014)
Antiangiogenesis therapy: an update after the first decade
Sandro De Falco
KOREAN JOURNAL OF INTERNAL MEDICINE (2014)
Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma
Matija Snuderl et al.
CELL (2013)
A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer
Andrew X. Zhu et al.
CLINICAL CANCER RESEARCH (2013)
Efficacy, Safety, Pharmacokinetics, and Biomarkers of Cediranib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
Andrew X. Zhu et al.
CLINICAL CANCER RESEARCH (2013)
Placental growth factor supports neuroendocrine tumor growth and predicts disease prognosis in patients
Georg Hilfenhaus et al.
ENDOCRINE-RELATED CANCER (2013)
Inhibition of Stromal PlGF Suppresses the Growth of Prostate Cancer Xenografts
Karin Zins et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Proteolytic Processing Regulates Placental Growth Factor Activities
Daniel C. Hoffmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Tumor associated macrophages and neutrophils in tumor progression
Maria R. Galdiero et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine-induced mouse model
Femke Heindryckx et al.
JOURNAL OF HEPATOLOGY (2013)
Placental Growth Factor (PlGF)-Specific Uptake in Tumor Microenvironment of 89Zr-Labeled PlGF Antibody RO5323441
Thijs H. Oude Munnink et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma
Shih-Jung Cheng et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2013)
Exploratory investigation of eight circulating plasma markers in brain tumor patients
Aysegul Ilhan-Mutlu et al.
NEUROSURGICAL REVIEW (2013)
Elevated PLGF contributes to small-cell lung cancer brain metastasis
B. Li et al.
ONCOGENE (2013)
The Association of Alternate VEGF Ligands with Resistance to Anti-VEGF Therapy in Metastatic Colorectal Cancer
Christopher H. Lieu et al.
PLOS ONE (2013)
Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs
Eva-Maria Eleonora Hedlund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth
Xiaojuan Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The Basis for the Distinct Biological Activities of Vascular Endothelial Growth Factor Receptor-1 Ligands
Andrey Anisimov et al.
SCIENCE SIGNALING (2013)
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors
Hope E. Uronis et al.
CANCER MEDICINE (2013)
Flt-1 in colorectal cancer cells is required for the tumor invasive effect of placental growth factor through a p38-MMP9 pathway
Shu-Chen Wei et al.
JOURNAL OF BIOMEDICAL SCIENCE (2013)
Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer
Else Maae et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Hepatocyte-Stellate Cell Cross-Talk in the Liver Engenders a Permissive Inflammatory Microenvironment That Drives Progression in Hepatocellular Carcinoma
Cedric Coulouarn et al.
CANCER RESEARCH (2012)
A Phase I Trial and Pharmacokinetic Study of Aflibercept (VEGF Trap) in Children with Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report
Julia Glade Bender et al.
CLINICAL CANCER RESEARCH (2012)
Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model
Femke Heindryckx et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Role of placenta growth factor in cancer and inflammation
Ki-Jo Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2012)
The discovery of placenta growth factor and its biological activity
Sandro De Falco
EXPERIMENTAL AND MOLECULAR MEDICINE (2012)
Inhibition of placenta growth factor with TB-403: a novel antiangiogenic cancer therapy
Dorte Lisbet Nielsen et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites
Nicoletta Colombo et al.
GYNECOLOGIC ONCOLOGY (2012)
CD105 and placental growth factor - Potent prognostic factors in childhood acute lymphoblastic leukaemia
Patrycja Sujka-Kordowska et al.
LEUKEMIA RESEARCH (2012)
Efficacy, Safety, and Biomarkers of Single- Agent Bevacizumab Therapy in Patients with Advanced Hepatocellular Carcinoma
Valerie Boige et al.
ONCOLOGIST (2012)
The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis
Melissa J. Cudmore et al.
NATURE COMMUNICATIONS (2012)
PlGF: A Multitasking Cytokine with Disease-Restricted Activity
Mieke Dewerchin et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Correlation of Circulating Angiogenic Factors with Circulating Tumor Cells and Disease Recurrence in Patients Undergoing Curative Resection for Colorectal Liver Metastases
Nuh N. Rahbari et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer
Nuh N. Rahbari et al.
BMC CANCER (2011)
Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer
F. Loupakis et al.
BRITISH JOURNAL OF CANCER (2011)
HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PIGF
Charlotte Rolny et al.
CANCER CELL (2011)
Loss or Inhibition of Stromal-Derived PIGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia
Thomas Schmidt et al.
CANCER CELL (2011)
Proangiogenic Factor PlGF Programs CD11b+ Myelomonocytes in Breast Cancer during Differentiation of Their Hematopoietic Progenitors
Julien Laurent et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept
John F. de Groot et al.
CLINICAL CANCER RESEARCH (2011)
Placental Growth Factor Upregulation Is a Host Response to Antiangiogenic Therapy
Rebecca G. Bagley et al.
CLINICAL CANCER RESEARCH (2011)
Phase I/II and Pharmacodynamic Study of Dovitinib (TKI258), an Inhibitor of Fibroblast Growth Factor Receptors and VEGF Receptors, in Patients with Advanced Melanoma
Kevin B. Kim et al.
CLINICAL CANCER RESEARCH (2011)
Monoclonal Antibody TB-403: A First-in-Human, Phase I, Double-Blind, Dose Escalation Study Directed Against Placental Growth Factor in Healthy Male Subjects
Titti Martinsson-Niskanen et al.
CLINICAL THERAPEUTICS (2011)
Inhibition of Placental Growth Factor Activity Reduces the Severity of Fibrosis, Inflammation, and Portal Hypertension in Cirrhotic Mice
Christophe Van Steenkiste et al.
HEPATOLOGY (2011)
Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue
Hua-Xiang Xu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
HCC and angiogenesis: possible targets and future directions
Andrew X. Zhu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Peter Carmeliet et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Placenta Growth Factor-1 Exerts Time-Dependent Stabilization of Adherens Junctions Following VEGF-Induced Vascular Permeability
Jun Cai et al.
PLOS ONE (2011)
Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy
Jenny Yao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Angiogenesis: A Target in Solid Tumors, Also in Leukemia?
Thomas Schmidt et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2011)
Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model
Sandra R. Brave et al.
ANGIOGENESIS (2010)
Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement
A. P. Taylor et al.
BRITISH JOURNAL OF CANCER (2010)
Premetastatic Lung Niche: Is Vascular Endothelial Growth Factor Receptor 1 Activation Required?
Dan G. Duda et al.
CANCER RESEARCH (2010)
Anti-Placental Growth Factor Reduces Bone Metastasis by Blocking Tumor Cell Engraftment and Osteoclast Differentiation
Lieve Coenegrachts et al.
CANCER RESEARCH (2010)
A Placental Growth Factor Variant Unable to Recognize Vascular Endothelial Growth Factor (VEGF) Receptor-1 Inhibits VEGF-Dependent Tumor Angiogenesis via Heterodimerization
Valeria Tarallo et al.
CANCER RESEARCH (2010)
PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth
Carlos Bais et al.
CELL (2010)
Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease
Sara Van de Veire et al.
CELL (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy
Amir Abdollahi et al.
DRUG RESISTANCE UPDATES (2010)
EXPRESSION OF PLACENTA GROWTH FACTOR: AN INDEPENDENT FACTOR FOR PREDICTION OF PROGRESSION AND PROGNOSIS OF ORAL CANCER
Shih-Jung Cheng et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)
Biomarkers as Predictors of Response to Treatment with Motesanib in Patients with Progressive Advanced Thyroid Cancer
Michael B. Bass et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
NFAT1 Mediates Placental Growth Factor-Induced Myelomonocytic Cell Recruitment via the Induction of TNF-α
Yanping Ding et al.
JOURNAL OF IMMUNOLOGY (2010)
Vascular endothelial growth factor B controls endothelial fatty acid uptake
Carolina E. Hagberg et al.
NATURE (2010)
Ribosome Display and Selection of Human Anti-Placental Growth Factor scFv Derived from Ovarian Cancer Patients
Fang Li et al.
PROTEIN AND PEPTIDE LETTERS (2010)
Antimyeloangiogenic Therapy for Cancer by Inhibiting PIGF
Sonja Loges et al.
CLINICAL CANCER RESEARCH (2009)
Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
Andrew X. Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Development of targeted angiogenic medicine
S. Loges et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
VEGFR1-activity-independent metastasis formation Kaplan et al. reply
Rosandra N. Kaplan et al.
NATURE (2009)
VEGFR1-activity-independent metastasis formation
Michelle R. Dawson et al.
NATURE (2009)
Biomarkers of response and resistance to antiangiogenic therapy
Rakesh K. Jain et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
VEGFR1 Activity Modulates Myeloid Cell Infiltration in Growing Lung Metastases but Is Not Required for Spontaneous Metastasis Formation
Michelle R. Dawson et al.
PLOS ONE (2009)
Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature
Eva-Maria Hedlund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Measurement of Phosphorylated Extracellular Signal-Regulated Kinase 1 and 2 in an Undergraduate Teaching Laboratory with ALPHAscreen Technology
Debbie L. Hay
SCIENCE SIGNALING (2009)
Flt-1 signaling in macrophages promotes glioma growth in vivo
Mark Kerber et al.
CANCER RESEARCH (2008)
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma
Brian I. Rini et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
Christian Fischer et al.
NATURE REVIEWS CANCER (2008)
Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during β cell carcinogenesis
Tibor Schomber et al.
CANCER RESEARCH (2007)
Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels
Christian Fischer et al.
CELL (2007)
Down-regulation of placenta growth factor by promoter hypermethylation in human lung and colon carcinoma
Xu Lei et al.
MOLECULAR CANCER RESEARCH (2007)
Placenta growth factor not vascular endothelial growth factor A or C can predict the early recurrence after radical resection of hepatocellular carcinoma
Ming-Chih Ho et al.
CANCER LETTERS (2007)
Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts
Alice P. Taylor et al.
MOLECULAR CANCER THERAPEUTICS (2007)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
Macrophages regulate the angiogenic switch in a mouse model of breast cancer
Elaine Y. Lin et al.
CANCER RESEARCH (2006)
Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer
Yan Wu et al.
CLINICAL CANCER RESEARCH (2006)
Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor
Marcella Marcellini et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization
Bin Li et al.
FASEB JOURNAL (2006)
Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models
L Xu et al.
CANCER RESEARCH (2006)
Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis
J Condeelis et al.
CELL (2006)
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
RN Kaplan et al.
NATURE (2005)
Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A
H Roy et al.
HUMAN GENE THERAPY (2005)
Placenta growth factor is over-expressed and has prognostic value in human breast cancer
C Parr et al.
EUROPEAN JOURNAL OF CANCER (2005)
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: Continued experience of a phase I trial in rectal cancer patients
CG Willett et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Tie2 identifies a hematopoietic monocytes required for tumor lineage of proangiogenic vessel formation and a mesenchymal population of pericyte progenitors
M De Palma et al.
CANCER CELL (2005)
Placenta growth factor expression is correlated with survival of patients with colorectal cancer
SC Wei et al.
GUT (2005)
The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer
CN Chen et al.
CANCER LETTERS (2004)
Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders
M Autiero et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
M Autiero et al.
NATURE MEDICINE (2003)
Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: Potential relationship to post-therapy tumor angiogenesis and recurrence
AP Taylor et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis
SF Schoppmann et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers
A Eriksson et al.
CANCER CELL (2002)
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
P Carmeliet et al.
NATURE MEDICINE (2001)
分享论文
